Feature Channels: Immunology

Filters close
Released: 28-Sep-2023 6:05 AM EDT
Researchers find potential way to tweak immune system to help it fight tuberculosis
Boston University

Tuberculosis is old—ancient even. The infectious bacterial disease that plagued Old Testament Israelites and took down pharaohs was eventually stunted by vaccinations, antibiotics, and public health measures like isolation, but it hasn’t been cured yet. More than a million people around the world still die from TB every year.

21-Sep-2023 10:05 AM EDT
DoD Scientists Develop Potential Cure for Rabies Infection
Uniformed Services University of the Health Sciences (USU)

A single-dose therapy has been developed that is highly effective against lyssavirus infection (rabies), one of the deadliest known viral infections of humans.

Newswise: Study shows how brain tumors make certain immune cells turn traitor
Released: 27-Sep-2023 2:05 PM EDT
Study shows how brain tumors make certain immune cells turn traitor
Ludwig Cancer Research

A Ludwig Cancer Research study has for the first time exhaustively analyzed neutrophils that reside in brain tumors, detailing how the immune cells support brain cancer survival and how they’re turned by the tumor microenvironment into enablers of malignant growth.

Released: 27-Sep-2023 12:50 PM EDT
Stay informed on women's health issues in the Women's Health channel
Newswise

Below are some of the latest headlines in the Women's Health channel on Newswise.

Released: 27-Sep-2023 10:05 AM EDT
Edward Garon receives $3.5 million from NIH to personalize immunotherapy based on individual patients’ mutations
University of California, Los Angeles (UCLA), Health Sciences

Dr. Edward Garon, professor of medicine at the David Geffen School of Medicine at UCLA and director of the Signal Transduction and Therapeutics Program at the UCLA Jonsson Comprehensive Cancer Center, was awarded two grants totaling over $3.5 million from the National Institutes of Health to help improve outcomes for patients with early and advanced stages of non-small cell lung cancer.

Newswise: Wistar President and CEO Dario Altieri, M.D., honored by Justinian Society of Philadelphia for Civic Engagement and Leadership
Released: 26-Sep-2023 1:05 PM EDT
Wistar President and CEO Dario Altieri, M.D., honored by Justinian Society of Philadelphia for Civic Engagement and Leadership
Wistar Institute

Dario C. Altieri, M.D., Wistar president and CEO, will be honored by the Justinian Foundation and Society of Philadelphia for exemplifying the finest qualities of scholarship, civic leadership and integrity.

Released: 26-Sep-2023 11:05 AM EDT
RPI Researcher of Circadian Rhythms Receives $2 Million Grant
Rensselaer Polytechnic Institute (RPI)

With daylight savings time ending soon, we anticipate a change in the timing of daylight hours with the sunrise occurring earlier in the morning.

Released: 26-Sep-2023 9:30 AM EDT
The American Association of Immunologists Announces 2023 Recipients of the Careers in Immunology Fellowships
American Association of Immunologists (AAI)

The American Association of Immunologists awards thirteen principal investigators one year of salary support for trainees

Released: 26-Sep-2023 6:05 AM EDT
Distinct immune, hormone responses shed light on mysteries of long COVID
Yale University

People who have experienced brain fog, confusion, pain, and extreme fatigue for months or longer after being infected with the COVID-19 virus exhibit different immune and hormonal responses to the virus than those not diagnosed with long COVID.

Newswise: People with Long COVID Have Distinct Hormonal and Immune Differences From Those Without This Condition
21-Sep-2023 8:05 AM EDT
People with Long COVID Have Distinct Hormonal and Immune Differences From Those Without This Condition
Mount Sinai Health System

Research conducted at Mount Sinai and Yale confirms long COVID is a biological disease by showing blood biomarkers that can predict who has it

Released: 25-Sep-2023 10:15 AM EDT
The American Association of Immunologists Announces 2023 Recipients of the Travel for Techniques Awards Program
American Association of Immunologists (AAI)

AAI awarded four scientists funds for trips to laboratories to learn new research techniques

Released: 22-Sep-2023 10:50 AM EDT
Study details immune cells vital to success of vaccines against coronavirus
NYU Langone Health

A study has revealed new details about a key population of immune system cells critical to successful vaccination against the pandemic virus, SARS-CoV-2.

Newswise: Scientists Reveal Intricate Mechanisms Cells Use to Build Protein Destruction Signals
Released: 21-Sep-2023 1:45 PM EDT
Scientists Reveal Intricate Mechanisms Cells Use to Build Protein Destruction Signals
University of North Carolina School of Medicine

Scientists revealed the intercellular choreography that governs protein regulation, including how unwanted proteins are tagged for degradation, an important player in human health and disease.

Released: 21-Sep-2023 12:00 PM EDT
MD Anderson Research Highlights for September 21, 2023
University of Texas MD Anderson Cancer Center

The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back.

Newswise: Combination of cancer vaccine and T cell therapy benefits patients with advanced ovarian cancer
Released: 21-Sep-2023 11:05 AM EDT
Combination of cancer vaccine and T cell therapy benefits patients with advanced ovarian cancer
Ludwig Cancer Research

A Ludwig Cancer Research study has shown that combining adoptive T cell therapy (ACT) with an innovative, personalized cancer vaccine under development at the Lausanne Branch of the Ludwig Institute for Cancer Research can benefit patients with late-stage, drug-resistant ovarian cancer.

19-Sep-2023 5:05 PM EDT
UCSF QBI, University College London, and Mount Sinai Identify Shared Molecular Mechanisms Across SARS-CoV-2 Variants that Allow Virus to Thrive Despite Vaccination
Mount Sinai Health System

In a study published online in CELL today, scientists at UCSF QBI, University College London and the Icahn School of Medicine at Mount Sinai reported breakthrough findings on convergent evolutionary mechanisms shared by COVID-19 variants, allowing them to overcome both adaptive and innate immune system barriers.

Released: 20-Sep-2023 12:05 PM EDT
Genetic Biomarker May Predict Severity of Food Allergy
Ann and Robert H. Lurie Children's Hospital of Chicago

Researchers from Ann & Robert H. Lurie Children’s Hospital of Chicago and colleagues reported for the first time that a genetic biomarker may be able to help predict the severity of food allergy reactions.

Newswise: Disrupting A Core Metabolic Process In T Cells May Improve Their Therapeutic Efficacy
Released: 20-Sep-2023 11:00 AM EDT
Disrupting A Core Metabolic Process In T Cells May Improve Their Therapeutic Efficacy
Ludwig Cancer Research

In exploring an aspect of how killer T cells generate the raw materials required for their proliferation, a Ludwig Cancer Research study has uncovered an unexpected link between the immune cells’ metabolism, regulation of gene expression, persistence and functional efficacy that could be exploited using existing drugs to improve cancer immunotherapy.

Newswise: Exercise boosts anti-cancer immunity and reduces inflammation in Lynch Syndrome patients
19-Sep-2023 6:00 AM EDT
Exercise boosts anti-cancer immunity and reduces inflammation in Lynch Syndrome patients
University of Texas MD Anderson Cancer Center

Regular and intense aerobic exercise may reduce the risk of colorectal cancer in patients with Lynch Syndrome (LS) by improving the immune system's ability to detect and remove potentially harmful cells, according to researchers at The University of Texas MD Anderson Cancer Center.

   
Released: 18-Sep-2023 11:05 AM EDT
Personalized combination treatment turns on an immunometabolic switch to effectively control an aggressive form of prostate cancer
University of Chicago Medical Center

Researchers at the University of Chicago Medicine Comprehensive Cancer Center established “proof-of-concept” for a new treatment approach that was able to effectively treat the most aggressive forms of prostate cancer.

Newswise: The Cancer Research Institute and the Lustgarten Foundation Announce INSPIRE Partnership to Jointly Support Pancreatic Cancer Immunotherapy Research 
Released: 18-Sep-2023 9:00 AM EDT
The Cancer Research Institute and the Lustgarten Foundation Announce INSPIRE Partnership to Jointly Support Pancreatic Cancer Immunotherapy Research 
Cancer Research Institute

The Cancer Research Institute and the Lustgarten Foundation Announce INSPIRE Partnership to Jointly Support Pancreatic Cancer Immunotherapy Research 

Released: 15-Sep-2023 8:05 AM EDT
New SARS-CoV-2 variant Eris on the rise
German Primate Center - Leibniz Institute for Primate Research

As a result of vaccination or infection, our immune system produces antibodies that attach to the spike protein of SARS-CoV-2, preventing the virus from entering and replicating within cells.

Released: 14-Sep-2023 11:05 AM EDT
Penn Medicine’s Carl June, MD, to Receive 2024 Breakthrough Prize in Life Sciences
Perelman School of Medicine at the University of Pennsylvania

CAR T cell therapy pioneer Carl June, MD, the Richard W. Vague Professor in Immunotherapy in the Perelman School of Medicine at the University of Pennsylvania and director of the Center for Cellular Immunotherapies (CCI) at Penn Medicine’s Abramson Cancer Center, has been named a winner of the 2024 Breakthrough Prize in Life Sciences.

Newswise: Combination immunotherapy treatment effective before lung cancer surgery
13-Sep-2023 2:00 PM EDT
Combination immunotherapy treatment effective before lung cancer surgery
University of Texas MD Anderson Cancer Center

Combination immunotherapy with the anti-PD-L1 monoclonal antibody durvalumab and other novel agents outperforms durvalumab alone in the neoadjuvant (pre-surgical) setting for early-stage non-small-cell lung cancer (NSCLC), according to researchers at The University of Texas MD Anderson Cancer Center.

Released: 12-Sep-2023 4:05 PM EDT
Ochsner MD Anderson First in Louisiana to Use CAR T cell Therapy to Treat Cancer in Adults
Ochsner Health

Ochsner MD Anderson Cancer Center at The Gayle and Tom Benson Cancer Center in New Orleans is proud to be the first institution in Louisiana to use CAR T cell therapy in adults, the revolutionary treatment for certain types of blood cancers.

Released: 12-Sep-2023 10:05 AM EDT
HIV: two autopsies reveal where the virus hides
Universite de Montreal

A research team shows for the first time that HIV reservoirs are concentrated in the spleen and lymph nodes, and that they can travel throughout the body.

Not for public release

This news release is embargoed until 11-Sep-2023 5:00 PM EDT Released to reporters: 5-Sep-2023 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 11-Sep-2023 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: AI more accurately identifies patients with advanced lung cancer that respond to immunotherapy and helps doctors select treatments
Released: 8-Sep-2023 1:05 PM EDT
AI more accurately identifies patients with advanced lung cancer that respond to immunotherapy and helps doctors select treatments
Yale Cancer Center/Smilow Cancer Hospital

Treatment planning for lung cancer can often be complex due to variations in assessing immune biomarkers. In a new study, Yale Cancer Center researchers at Yale School of Medicine used artificial intelligence (AI) tools and digital pathology to improve the accuracy of this process.

Newswise: New immunotherapy treatment brings hope to patients with advanced non-small cell lung cancer
Released: 8-Sep-2023 1:05 PM EDT
New immunotherapy treatment brings hope to patients with advanced non-small cell lung cancer
Yale Cancer Center/Smilow Cancer Hospital

Although immunotherapies have shown promise in treating non-small cell lung cancer (NSCLC), many patients still do not respond well, and those who do may eventually develop resistance.

Released: 8-Sep-2023 12:05 PM EDT
Albert Bendelac, pathologist and former chair of the University of Chicago Committee on Immunology, 1956-2023
University of Chicago Medical Center

Albert Bendelac, MD, PhD, the A.N. Pritzker Distinguished Service Professor of Pathology at the University of Chicago, died at his home on August 23, 2023, surrounded by family. He had just celebrated his 67th birthday.

7-Sep-2023 8:00 AM EDT
Fiber from crustaceans, insects, mushrooms promotes digestion
Washington University in St. Louis

Crustaceans, insects and mushrooms are rich sources of the dietary fiber chitin, which activates the immune system and benefits metabolism, according to a new study, in mice, led by researchers at Washington University School of Medicine in St. Louis.

Newswise: Immune cells move more independently than previously thought
Released: 7-Sep-2023 11:05 AM EDT
Immune cells move more independently than previously thought
University of Turku (Turun yliopisto)

Human immune cells are capable of coordinating their own movement more independently than previously thought.

Newswise: Immune System Plays Vital Role in Longer Multiple Myeloma Remission
Released: 6-Sep-2023 2:05 PM EDT
Immune System Plays Vital Role in Longer Multiple Myeloma Remission
Sylvester Comprehensive Cancer Center

A new study from researchers with Sylvester Comprehensive Cancer Center and other top-tier cancer centers highlights the vital role that the immune system plays in determining the duration of patients’ remission from multiple myeloma.

Released: 6-Sep-2023 10:55 AM EDT
T-Cells Infiltrate Brain, Cause Respiratory Distress in Condition Affecting the Immunocompromised
College of Veterinary Medicine, University of Illinois Urbana-Champaign

When an immunocompromised person’s system begins to recover and produce more white blood cells, it’s usually a good thing – unless they develop a potentially deadly inflammatory condition.

Released: 6-Sep-2023 8:00 AM EDT
MD Anderson and Panacea launch Manaolana Oncology to develop antibody-based therapies for cancer
University of Texas MD Anderson Cancer Center

MD Anderson and Panacea Venture announced the launch of Manaolana Oncology, a new company created to develop and advance antibody-based therapies against novel cancer targets.

Released: 5-Sep-2023 9:05 AM EDT
Investigadores de Mayo descubren que la vacuna puede reducir la gravedad de los síntomas del síndrome crónico de COVID
Mayo Clinic

Recibir la vacuna contra la COVID-19 podría significar no solo un menor riesgo de tener síndrome crónico de COVID, sino también la presencia de menos síntomas para quienes contraigan la afección.

Newswise: LJI scientists harness 'helper' T cells to treat tumors
31-Aug-2023 1:05 PM EDT
LJI scientists harness 'helper' T cells to treat tumors
La Jolla Institute for Immunology

La Jolla Institute for Immunology (LJI) scientists have published a pair of studies that show how we might harness CD4+ T cells while boosting the cancer-fighting power of CD8+ "killer" T cells.

25-Aug-2023 11:05 AM EDT
Study could help explain why certain brain tumors don’t respond well to immunotherapy
University of California, Los Angeles (UCLA), Health Sciences

A study led by researchers at the UCLA Jonsson Comprehensive Cancer Center sheds new light on why tumors that have spread to the brain from other parts of the body respond to immunotherapy while glioblastoma, an aggressive cancer that originates in the brain, does not.

Newswise: Sylvester researchers help identify mechanisms by which multiple myeloma escapes targeted immunotherapy
29-Aug-2023 4:30 PM EDT
Sylvester researchers help identify mechanisms by which multiple myeloma escapes targeted immunotherapy
Sylvester Comprehensive Cancer Center

Researchers at Sylvester Comprehensive Cancer Center are part of an international team of scientists who identified mechanisms by which some multiple myelomas become resistant to initially effective T-cell therapies. Article in Aug. 31 issue of Nature Medicine.

Released: 30-Aug-2023 1:15 PM EDT
Blood cell insights offer potential boost to lung cancer therapies
University of Edinburgh

Fresh discoveries about a type of immune cells could give lung cancer patients a more accurate prognosis and better identify who will benefit from immunotherapies.

Newswise: Enhancing Immune Defenses: Researchers Unveil the Secrets of Specialized T Cells to Conquer Tumors
28-Aug-2023 7:00 PM EDT
Enhancing Immune Defenses: Researchers Unveil the Secrets of Specialized T Cells to Conquer Tumors
University of California San Diego

Immunologists have uncovered new approaches to enhance protection from tumors and infections.

Newswise: Myocardial infarction, the number one cause of sudden death, may be treated by modulating the immune response
Released: 25-Aug-2023 12:00 AM EDT
Myocardial infarction, the number one cause of sudden death, may be treated by modulating the immune response
National Research Council of Science and Technology

Dr. Yoon Ki Joung and Dr. Juro Lee of the Biomaterials Research Center at the Korea Institute of Science and Technology (KIST), together with Prof. Hun-Jun Park and Dr. Bong-Woo Park of the Catholic University of Korea College of Medicine, have developed a new treatment for myocardial infarction that uses nanovesicles derived from fibroblasts with induced apoptosis to modulate the immune response.

18-Aug-2023 10:50 AM EDT
Scientists discover a previously unknown way cells break down proteins
Harvard Medical School

Short-lived proteins control gene expression in cells to carry out a number of vital tasks, from helping the brain form connections to helping the body mount an immune defense. These proteins are made in the nucleus and are quickly destroyed once they’ve done their job.

Released: 24-Aug-2023 11:05 AM EDT
Training immune cells to remove ‘trash’ helps resolve lung inflammation
University of Illinois Chicago

Acute lung injury occurs when our lung’s immune system response becomes hyperactivated and causes inflammation to continue unchecked. In fact, many deaths from COVID-19 were from acute lung injury.

Released: 23-Aug-2023 2:15 PM EDT
Study finds high levels of exposure to the COVID-19 virus may reduce protection provided by vaccination and prior infection
Yale University

High levels of exposure to the virus that causes COVID-19 may reduce or overcome the protection that vaccination and prior infection provides, according to a new study.

Newswise:Video Embedded mayo-researchers-find-vaccine-may-reduce-severity-of-long-haul-covid-symptoms
VIDEO
Released: 23-Aug-2023 12:50 PM EDT
Mayo researchers find vaccine may reduce severity of long-haul COVID symptoms
Mayo Clinic

Getting a COVID-19 vaccine may not only reduce a person's risk of getting long-haul COVID, but also could mean fewer symptoms for people who develop the condition.

Released: 23-Aug-2023 12:45 PM EDT
Research identifies immunosuppressed people are least likely to have COVID-19 antibodies
University of Nottingham

New research has identified which people with compromised immune systems are less likely to have COVID-19 antibodies - making them more vulnerable to a severe infection.

Newswise: Case Study: Overcoming Barriers to Venom Immunotherapy for Fire Ant Allergy Patients
Released: 23-Aug-2023 8:30 AM EDT
Case Study: Overcoming Barriers to Venom Immunotherapy for Fire Ant Allergy Patients
Ochsner Health

Dr. John Carlson, pediatric allergy and immunology specialist at Ochsner Health, shares a case study recently published in the Journal of Allergy and Clinical Immunology: In Practice.



close
1.83487